Vol 7, No 3 (2017)

Articles

Low intensity shock wave therapy for erectile dysfunction: 6 months followup results

Korneyev I.A., Telegin I.V., Davydov I.V., Matveev A.V., Rubanov D.V., Al-Shukri S.H.

Abstract

Introduction. Low intensity extracorporeal shock wave therapy (ESWT) is a novel promising method of treatment for men with erectile dysfunction (ED). The efficacy of ESWT is not clearly determined and need further investigation.

Aim of the study: To investigate 6 months followup efficacy and safety results from ESWT trial in patients with ED.

Patients and methods. This open-label, longitudinal observational study investigated 6 months followup results in 19 men (mean age = 59.5 years) with organic ED (including 6 (32%) patients with type 2 diabetes mellitus and 6 (32%) patients after nerve-sparing radical prostatectomy) treated with 5-session weekly ESWT protocol using DornierAries delivery system (7500 shock waves, 1500 each session, 4 Hz). Information about adverse events was recorded. Effectiveness was assessed according to the International Index of Erectile Function and Sexual Health Inventory for Men after the 5th ESWT session and also in 1, 3 and 6 months.

Results. No patient reported treatment-related adverse events. In 12 (63%), 11 (57%), 11 (57%) and 9 (47%) patients IIEF increased after the 5th ESWT session (also in 2 (33%) men with ED caused by radical prostatectomy), and in 1, 3, 6 months after treatment respectively, so the mean IIEF score in the group has become higher (p = 0.003, p = 0.050, p = 0.022, р > 0.1 respectively) as well as the IIEF general satisfaction domain score (p = 0.006 и p = 0.014, р = 0.011 и p = 0.028, respectively). Mean SHIM score growth was significantly higher after the 5th ESWT session only (р = 0.020), also in patients with diabetic ED (р = 0.041). Individual variability of both IIEF and SHIM scores after treatment was high, with IIEF lower in patients with advanced age (р = 0.015).

Conclusions. In 6 months followup ESWT was safe in all and effective in many patients with ED. High individual variability of treatment efficacy needs further evaluation.

Urology reports (St. - Petersburg). 2017;7(3):5-13
pages 5-13 views

Scientific background of telemedicine-based approaches for medical care organization in urology

Apolihin O.I., Shadjorkin I.A., Perhov V.I., Sabgajda T.P., Leonov S.A.

Abstract

The paper includes organizational issues of telemedicine usage in field of urology. Negative outcomes of an urological care had been described and classified. Proposed complex telemedicine system allows to decrease influence of a set of negative factors linked with bad outcomes in urology.

Urology reports (St. - Petersburg). 2017;7(3):14-21
pages 14-21 views

Neurological aspects of diagnosis and treatment of chronic prostatitis

Krupin V.N., Makhmudov Y.Y., Makhmudova L.A., Krupin A.V., Troshin V.D.

Abstract

In this study were analyzed the results of examination and treatment of patients with chronic prostatitis and vertebral neurogenic prostatopathy. Inclusion in the complex treatment of methods of correction of neurogenic disorders (segmental therapy, therapeutic gymnastics, psychotherapy, pharmacotherapy) showed high efficiency. Correction of the revealed neurological pathology and vertebral pathology as well, in most patients led to the elimination of not only neurological manifestations, but also symptoms of chronic prostatitis.

Urology reports (St. - Petersburg). 2017;7(3):22-27
pages 22-27 views

Urodynamic condition of lower urinary tract in patients with a benign prostatic hyperplasia who use dutasteride

Iziev M.M., Al-Shukri A.S., Tkachuk V.N.

Abstract

The aim of this research was to study the urodynamic condition of the lower urinary tract in patients with benign prostatic hyperplasia during their use of dutasteride and at a remote time after its completion. The condition of urodynamic of the lower urinary tract was studied in 311 patients. The duration of dutasteride use ranged from 6 to 48 months. The obtained data made it possible to conclude that in the treatment of patients with benign prostatic hypertension with dutasteride it is advisable to prescribe this drug continuously for at least 48 months.

Urology reports (St. - Petersburg). 2017;7(3):28-33
pages 28-33 views

Our own method of combined treatment of acute purulent pyelonephritis: first results

Anan’ev V.A., Antonov A.V.

Abstract

The article describes the author’s method of retroperitoneoscopic decapsulation of the kidney with removal of purulent foci, sanitation and drainage of the retroperitoneal space with subsequent catheterization of the renal artery with continuous intraarterial infusion of alprostadil in combined treatment of patients with acute purulent pyelonephritis. The results of treatment of 13 patients showed high efficiency as described above. The possibility and expediency of using of described technique is shown.

Urology reports (St. - Petersburg). 2017;7(3):34-37
pages 34-37 views

Evaluation of blood flow in prostate in patients with chronic bacterial prostatitis

Krupin V.N., Krupin A.V., Nashivochnikova N.A.

Abstract

73 patients with chronic bacterial prostatitis were undergone several methods of investigations, such as pelvic rheography, rheoprostatography, laser doppler flowmetry and ultrasonic dopplerography for studying its hemodynamics.The results obtained indicate a violation of the blood supply to the prostate, which depends not only of the severity of the inflammatory process, but on the degree of hemodynamic disturbances in the small pelvis too and caused by a violation of the tone of the vessels of the prostate as well.

Urology reports (St. - Petersburg). 2017;7(3):38-43
pages 38-43 views

The use of prostatic peptides in the treatment of prostate diseases

Uchvatkin G.V., Tatarinceva M.B.

Abstract

The article covers the possibilities of clinical use of bioregulatory peptides of the prostate in the treatment of urological diseases. The mechanisms of the therapeutic action of prostatic peptides are described. The author gives his own experience of using the drug Samprost in the treatment of patients with a urological disease.

Urology reports (St. - Petersburg). 2017;7(3):44-48
pages 44-48 views

Peyroni’s disease which imitated the large stone of urethra

Kazarov R.L., Korol E.I., Merkulov D.V., Vasil’ev A.V., Al-Shukri A.S.

Abstract

A clinical observation of Peyronie’s disease in patient, who had large fibrous plaque in a cavernous body, which imitated the stone of urethra. Clarification of the diagnosis was possible only after performing multi-slice computer tomography.

Urology reports (St. - Petersburg). 2017;7(3):49-51
pages 49-51 views

Diagnosis and theraphy of urinary infections. What should always remember (clinical lecture). Part 1

Borisov V.V.

Abstract

The clinical lecture is devoted to the systematization of the knowledge of a wide range of physicians and urologists about the importance of the problem of uncomplicated urinary tract infections, their prevalence in our country and the world, the causes and frequency of occurrence in children and adults, diagnostic features based on clinical manifestations of the disease, laboratory data taking into account the formation of biofilms, the presence of sexually transmitted diseases. A special place is given to the problem of recurrences of cystitis due to the anatomical features of the female urethra, the need and the possibilities for their correction. An important place in the lecture is devoted to the role of general practitioners, district therapists, nephrologists, urologists, gynecologists in outpatient examination and treatment of these patients.

Urology reports (St. - Petersburg). 2017;7(3):52-59
pages 52-59 views


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies